Results of phase III trial of EndostarTM (rh-endostatin, YH-16) in advanced non-smallcell lung cancer (NSCLC) patients - Sun, Y; Wang, J; Liu, Y (ASCO Annual Meeting Proceedings, 2005)
Abstract